RespireRx Pharmaceuticals Inc. (RSPI)

RespireRx Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	0.01	0	0	0	0.02	0.03
Cash & Short-Term Investments	0.01	0	0	0	0.02	0.03
Cash Growth	10503.33%	-93.70%	69.45%	-95.06%	-49.86%	-60.80%
Prepaid Expenses	0.05	0.02	0.03	0.03	0.03	0.04
Other Current Assets	0.06	-	0.18	0.05	-	0.05
Total Current Assets	0.11	0.02	0.21	0.09	0.05	0.12
Other Long-Term Assets	-	-	-	-	-	0
Total Assets	0.11	0.02	0.21	0.09	0.05	0.12
Accounts Payable	3.65	4.77	4.53	4.06	3.07	2.68
Accrued Expenses	2.7	3.3	2.61	1.54	2.08	1.3
Short-Term Debt	2.78	2.71	2.08	1.68	1.63	1.25
Other Current Liabilities	2.93	0.95	0.71	0.86	0.7	0.63
Total Current Liabilities	12.06	11.73	9.92	8.15	7.49	5.86
Other Long-Term Liabilities	0.34	0.17	0.29	-	-	-
Total Liabilities	12.41	11.9	10.22	8.15	7.49	5.86
Common Stock	0.3	0.13	0.1	0.07	0	0
Additional Paid-In Capital	164.16	164.03	163.83	162.65	159.04	158.64
Retained Earnings	-177.56	-176.06	-173.96	-170.81	-166.51	-164.39
Total Common Equity	-13.11	-11.9	-10.03	-8.09	-7.47	-5.75
Shareholders' Equity	-12.3	-11.88	-10.01	-8.06	-7.44	-5.73
Total Liabilities & Equity	0.11	0.02	0.21	0.09	0.05	0.12
Total Debt	2.78	2.71	2.08	1.68	1.63	1.25
Net Cash (Debt)	-2.77	-2.71	-2.08	-1.68	-1.62	-1.22
Net Cash Per Share	-0.02	-0.02	-0.02	-0.07	-4.14	-3.63
Filing Date Shares Outstanding	365.42	144.33	97.89	89.5	3.37	0.39
Total Common Shares Outstanding	298.33	125.54	97.89	71.27	0.42	0.39
Working Capital	-11.95	-11.71	-9.71	-8.06	-7.44	-5.74
Book Value Per Share	-0.04	-0.09	-0.10	-0.11	-17.88	-14.86
Tangible Book Value	-13.11	-11.9	-10.03	-8.09	-7.47	-5.75
Tangible Book Value Per Share	-0.04	-0.09	-0.10	-0.11	-17.88	-14.86

Updated Nov 17, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.